Generate a tailored SOP for Dr. Matthias Schwenkglenks. Improve your application with a focused, well-structured draft.
Matthias Schwenkglenks is a professor and the head of research at the Institute of Pharmaceutical Medicine at the University of Basel, Switzerland, where he has been since August 2003. He specializes in health economics, focusing on health economic evaluation and decision-analytic modeling. His work also encompasses epidemiology, outcomes research, health services research, and biostatistics, particularly in the development of risk models and advanced multivariable regression modeling. He was awarded the title of Professor by the Medical Faculty of the University of Zurich in November 2009 and has held various prominent positions, including the head of the Medical Economics Unit at the University of Zurich and the head of the Division of Medical Economics at Hirslanden Holding AG. Schwenkglenks has a comprehensive educational background, which includes a PhD in Epidemiology from the University of Basel and a Master of Public Health from the Universities of Basel, Bern, and Zurich. His extensive experience in researching observational and experimental studies underlines his expertise in health technology assessment and biostatistics.
Institute of Pharmaceutical Medicine (ECPM), University of Basel • Switzerland
Leading research initiatives in pharmaceutical medicine.
University of Zurich • Switzerland
Oversaw projects related to medical economics and health services research.
Hirslanden Holding AG • Zürich, Switzerland
Managed the division focused on medical economics.
University Hospital Zürich • Switzerland
Engaged in research concerning medical economics.
University Hospital Tübingen • Germany
Provided nursing care in the internal intensive care unit.
The University of Basel generally requires C1 level proficiency in the language of instruction. For most English-taught Masters, TOEFL (min 92-95) or IELTS (min 7.0) is the standard.